More than 2000 drugs now in cancer immunotherapy race – Reuters
Endpoints News |
More than 2000 drugs now in cancer immunotherapy race
Reuters “The field is very promising and has the potential to deliver many breakthroughs to change the standard of care of many cancer types,” Shalabi and colleagues wrote in the journal. “However, it is also very crowded, fragmented and uncoordinated with … There are 2004 cancer immunotherapies crowding into the pipeline. Now what? |
